Clinical trial
A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With…
NCT00326131 · Bristol-Myers Squibb, Industry · Terminated
Key facts
| NCT number | NCT00326131 |
|---|---|
| Title | A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer |
| Official title | Pharmacokinetics and Metabolism of [14C] BMS-275183 in Patients With Advanced Cancer |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | Oral Taxane |
| Enrollment | 6 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2007 |
| First posted | May 16, 2006 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: